Anhui Huaheng Biotechnology Co. Ltd. A (SHG:688639) — Stock Price

CN¥18.09 CNY
▲ 3.43% today

Anhui Huaheng Biotechnology Co. Ltd. A (SHG:688639) is currently trading at CN¥18.09 CNY, up 3.43% today. Over the past 52 weeks, shares have ranged between CN¥15.40 and CN¥41.34. This page tracks Anhui Huaheng Biotechnology Co. Ltd. A's live share price on the SHG exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Anhui Huaheng Biotechnology Co. Ltd. A (688639) total market value.

Anhui Huaheng Biotechnology Co. Ltd. A (688639) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Anhui Huaheng Biotechnology Co. Ltd. A's daily closing share price and trading volume on the SHG exchange over the past year, giving a clear view of recent price momentum and liquidity.

Anhui Huaheng Biotechnology Co. Ltd. A Income Statement — Revenue, Profit & Earnings by Year

Anhui Huaheng Biotechnology Co. Ltd. A's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue CN¥2.86 Billion CN¥2.18 Billion CN¥1.94 Billion CN¥1.42 Billion CN¥954.10 Million
Cost of Revenue CN¥2.25 Billion CN¥1.64 Billion CN¥1.16 Billion CN¥870.26 Million CN¥646.00 Million
Gross Profit CN¥608.62 Million CN¥539.66 Million CN¥782.37 Million CN¥548.39 Million CN¥308.10 Million
Research & Development CN¥151.20 Million CN¥124.05 Million CN¥108.82 Million CN¥78.61 Million CN¥52.84 Million
SG&A CN¥171.87 Million CN¥157.89 Million CN¥121.68 Million CN¥112.90 Million CN¥64.67 Million
Total Operating Expenses CN¥478.97 Million CN¥340.34 Million CN¥271.47 Million CN¥206.35 Million CN¥121.75 Million
Operating Income CN¥129.65 Million CN¥199.32 Million CN¥510.90 Million CN¥342.04 Million CN¥186.34 Million
EBITDA CN¥384.19 Million CN¥381.09 Million CN¥618.31 Million CN¥402.67 Million CN¥239.94 Million
EBIT CN¥169.39 Million CN¥242.44 Million CN¥519.47 Million CN¥343.52 Million CN¥192.44 Million
Interest Expense CN¥47.52 Million CN¥41.03 Million CN¥13.20 Million CN¥540.25K CN¥1.65 Million
Income Before Tax CN¥125.56 Million CN¥201.41 Million CN¥506.27 Million CN¥342.98 Million CN¥190.79 Million
Income Tax Expense CN¥1.70 Million CN¥16.85 Million CN¥59.67 Million CN¥23.64 Million CN¥22.55 Million
Net Income CN¥132.41 Million CN¥189.52 Million CN¥449.06 Million CN¥320.03 Million CN¥168.24 Million

Anhui Huaheng Biotechnology Co. Ltd. A Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Anhui Huaheng Biotechnology Co. Ltd. A's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets CN¥5.77 Billion CN¥4.99 Billion CN¥3.97 Billion CN¥2.03 Billion CN¥1.47 Billion
Total Current Assets CN¥1.46 Billion CN¥1.35 Billion CN¥1.05 Billion CN¥863.06 Million CN¥852.50 Million
Cash & Equivalents — — — — —
Short-term Investments — — — CN¥200.31 Million CN¥341.06 Million
Net Receivables CN¥587.63 Million CN¥391.11 Million CN¥318.43 Million CN¥339.95 Million CN¥228.82 Million
Inventory CN¥532.13 Million CN¥406.92 Million CN¥226.46 Million CN¥135.51 Million CN¥106.21 Million
Property, Plant & Equipment — — — — —
Goodwill — — — — —
Total Liabilities CN¥3.14 Billion CN¥2.43 Billion CN¥2.14 Billion CN¥545.44 Million CN¥290.98 Million
Total Current Liabilities CN¥1.34 Billion CN¥1.60 Billion CN¥1.68 Billion CN¥388.75 Million CN¥182.89 Million
Long-term Debt CN¥1.57 Billion CN¥637.81 Million CN¥304.93 Million — —
Net Debt CN¥1.82 Billion CN¥897.15 Million CN¥867.07 Million CN¥-68.24 Million CN¥-103.29 Million
Total Stockholder Equity CN¥2.65 Billion CN¥2.56 Billion CN¥1.83 Billion CN¥1.48 Billion CN¥1.18 Billion
Retained Earnings CN¥1.14 Billion CN¥1.08 Billion CN¥1.05 Billion CN¥721.27 Million CN¥462.84 Million

Anhui Huaheng Biotechnology Co. Ltd. A Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Anhui Huaheng Biotechnology Co. Ltd. A generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow CN¥104.55 Million CN¥199.79 Million CN¥304.28 Million CN¥357.43 Million CN¥95.70 Million
Capital Expenditures CN¥636.73 Million CN¥923.51 Million CN¥1.27 Billion CN¥456.35 Million CN¥180.63 Million
Free Cash Flow CN¥-532.18 Million CN¥-723.72 Million CN¥-967.75 Million CN¥-98.92 Million CN¥-84.93 Million
Investing Cash Flow CN¥-643.46 Million CN¥-930.09 Million CN¥-1.13 Billion CN¥-342.00 Million CN¥-511.82 Million
Financing Cash Flow CN¥409.22 Million CN¥780.75 Million CN¥1.02 Billion CN¥6.46 Million CN¥476.98 Million
Dividends Paid CN¥110.81 Million CN¥183.41 Million CN¥97.56 Million CN¥59.73 Million CN¥36.40 Million
Stock-Based Compensation — — — CN¥36.43 Million CN¥2.25 Million
Depreciation CN¥214.80 Million CN¥138.66 Million CN¥98.84 Million CN¥59.15 Million CN¥47.50 Million
Change in Cash CN¥-130.84 Million CN¥62.47 Million CN¥205.52 Million CN¥27.13 Million CN¥60.17 Million

Anhui Huaheng Biotechnology Co. Ltd. A Earnings History — EPS Actual vs. Analyst Estimates

Track Anhui Huaheng Biotechnology Co. Ltd. A's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 22, 2026 0.17 0.25 -32.00%
Mar 17, 2026 -0.14 0.02 -800.00%
Aug 27, 2025 0.26 0.40 -35.00%
Apr 22, 2025 0.04 0.27 -85.19%
Feb 25, 2025 0.12 0.27 -55.56%
Oct 28, 2024 0.08 0.72 -88.89%
Aug 27, 2024 0.39 0.61 -36.07%
Apr 21, 2024 0.53 0.53 +0.00%